Polycomb genes and cancer: time for clinical application? - PubMed (original) (raw)
Review
Polycomb genes and cancer: time for clinical application?
Francesco Crea et al. Crit Rev Oncol Hematol. 2012 Aug.
Abstract
Polycomb group genes (PcGs) are epigenetic effectors, essential for stem cell self-renewal and pluripotency. Two main Polycomb repressive complexes (PRC1, PRC2) mediate gene silencing through histone post-translational modifications. PcGs have been the focus of investigation in cancer research. Many cancer types show an over-expression of PcGs, predicting poor prognosis, metastasis and chemoresistance. Genetic polymorphisms of EZH2 (a PRC2 component) are significantly associated to lung cancer risk. Recently, 3-Deazaneplanocin A (DZNeP) was identified as an efficient inhibitor of PRC2 activity. DZNeP impairs cancer stem cell self-renewal and tumorigenicity. Despite the well-established role of PcGs in cancer stem cell biology, few studies dissected the clinical significance of these genes. In this paper, we explore PcGs as predictive and prognostic factors in oncology, with particular emphasis on what they can add to current biomarkers. We also propose a model for the rational development of DZNeP-based anticancer regimens and suggest the therapeutic applications of this drug.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Targeting of cancer stem cells by inhibitors of DNA and histone methylation.
Momparler RL, Côté S. Momparler RL, et al. Expert Opin Investig Drugs. 2015;24(8):1031-43. doi: 10.1517/13543784.2015.1051220. Epub 2015 May 25. Expert Opin Investig Drugs. 2015. PMID: 26004134 Review. - 3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer.
Mayr C, Wagner A, Stoecklinger A, Jakab M, Illig R, Berr F, Pichler M, Di Fazio P, Ocker M, Neureiter D, Kiesslich T. Mayr C, et al. Anticancer Res. 2015 Sep;35(9):4697-705. Anticancer Res. 2015. PMID: 26254359 - Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer.
Crea F, Hurt EM, Mathews LA, Cabarcas SM, Sun L, Marquez VE, Danesi R, Farrar WL. Crea F, et al. Mol Cancer. 2011 Apr 18;10:40. doi: 10.1186/1476-4598-10-40. Mol Cancer. 2011. PMID: 21501485 Free PMC article. - TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
Cheng LL, Itahana Y, Lei ZD, Chia NY, Wu Y, Yu Y, Zhang SL, Thike AA, Pandey A, Rozen S, Voorhoeve PM, Yu Q, Tan PH, Bay BH, Itahana K, Tan P. Cheng LL, et al. Clin Cancer Res. 2012 Aug 1;18(15):4201-12. doi: 10.1158/1078-0432.CCR-12-0036. Epub 2012 Jun 6. Clin Cancer Res. 2012. PMID: 22675170 - The role of polycomb repressive complexes in biliary tract cancer.
Mayr C, Neureiter D, Wagner A, Pichler M, Kiesslich T. Mayr C, et al. Expert Opin Ther Targets. 2015 Mar;19(3):363-75. doi: 10.1517/14728222.2014.986460. Epub 2014 Nov 26. Expert Opin Ther Targets. 2015. PMID: 25424424 Review.
Cited by
- SMOX expression predicts the prognosis of non-small cell lung cancer.
Huang Z, Wang S, Zhang HJ, Zhou YL, Shi JH. Huang Z, et al. Ann Transl Med. 2021 Jul;9(13):1048. doi: 10.21037/atm-21-998. Ann Transl Med. 2021. PMID: 34422960 Free PMC article. - 3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells.
Girard N, Bazille C, Lhuissier E, Benateau H, Llombart-Bosch A, Boumediene K, Bauge C. Girard N, et al. PLoS One. 2014 May 22;9(5):e98176. doi: 10.1371/journal.pone.0098176. eCollection 2014. PLoS One. 2014. PMID: 24852755 Free PMC article. - MUC1-C activates BMI1 in human cancer cells.
Hiraki M, Maeda T, Bouillez A, Alam M, Tagde A, Hinohara K, Suzuki Y, Markert T, Miyo M, Komura K, Ahmad R, Rajabi H, Kufe D. Hiraki M, et al. Oncogene. 2017 May 18;36(20):2791-2801. doi: 10.1038/onc.2016.439. Epub 2016 Nov 28. Oncogene. 2017. PMID: 27893710 Free PMC article. - Epigenetic Aberrations in Multiple Myeloma.
Caprio C, Sacco A, Giustini V, Roccaro AM. Caprio C, et al. Cancers (Basel). 2020 Oct 15;12(10):2996. doi: 10.3390/cancers12102996. Cancers (Basel). 2020. PMID: 33076518 Free PMC article. Review. - The role of epigenetic regulation in stem cell and cancer biology.
van Vlerken LE, Hurt EM, Hollingsworth RE. van Vlerken LE, et al. J Mol Med (Berl). 2012 Jul;90(7):791-801. doi: 10.1007/s00109-012-0917-9. Epub 2012 Jun 2. J Mol Med (Berl). 2012. PMID: 22660276 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources